| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 44.193 | 30.149 | 6.928 | 0 | 0 | 0 | - | - | - | - |
| Total Income - EUR | 44.193 | 30.153 | 6.928 | 0 | 0 | 0 | - | - | - | - |
| Total Expenses - EUR | 46.125 | 30.516 | 14.496 | 4.773 | 69 | 0 | - | - | - | - |
| Gross Profit/Loss - EUR | -1.932 | -363 | -7.568 | -4.773 | -69 | 0 | - | - | - | - |
| Net Profit/Loss - EUR | -3.258 | -1.268 | -7.696 | -4.773 | -69 | 0 | - | - | - | - |
| Employees | 0 | 0 | 1 | 1 | 0 | 0 | - | - | - | - |
Check the financial reports for the company - Dalum Medical Devices Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - |
| Current Assets | 25.645 | 29.611 | 22.925 | 22.506 | 21.684 | 21.273 | - | - | - | - |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - |
| Receivables | 24.348 | 29.542 | 22.804 | 22.522 | 21.596 | 21.186 | - | - | - | - |
| Cash | 1.297 | 70 | 120 | -16 | 89 | 87 | - | - | - | - |
| Shareholders Funds | -7.873 | -9.061 | -16.603 | -21.071 | -20.731 | -20.338 | - | - | - | - |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | - | - | - | - |
| Debts | 33.519 | 38.672 | 39.528 | 43.577 | 42.416 | 41.612 | - | - | - | - |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Dalum Medical Devices Srl